2006, Number 1
<< Back Next >>
Bol Clin Hosp Infant Edo Son 2006; 23 (1)
Disseminated Coccidioidomicosis with Lymphatic Nodes Involvement. Experience at the Hospital Infantil del Estado de Sonora (1983-2004).
Cano-Rangel MA, Dorame-Castillo R, Gómez-Rivera N, Contreras-Soto J
Language: Spanish
References: 18
Page: 10-14
PDF size: 43.99 Kb.
ABSTRACT
Coccidioidomicosis is deep mycosis, known as “desert rheumatism “or “Valley Fever”. It’s caused by a dimorphic fungus,
Coccidioides immitis or
posadasii, cases are limited to arid zones.
It’s a fungus disease proper from the American continent, which extends from California to Argentina. In Mexico the zone with most cases is between the northern states of Baja California, Sonora, Chihuahua, Coahuila and Nuevo Leon.
We reviewed 13 cases, the mean age was of 6.9 years, without significant difference with sex, the most important clinical manifestations included weight loss in 6 patients (46.1%), fever in 10 (76.9%), nodule erythema nodosum in 3 (23%), erythema multiforme in 1 (8%) and with arthralgias 1(8%).
Initial treatment in every case included amphotericin B and in 8 cases it was continued with azole, presenting less nephrotoxicity than referred in other publications.
The purpose of this analysis is to show our experience in treatment of disseminated coccidioidomicosis with lymphatic
nodule affection in 13 patients attended at the Hospital Infantil del Estado de Sonora, Mexico.
REFERENCES
1.- Castañon OLR, Aroch CA, y cols. Coccidioidomicosis y su escaso conocimiento en nuestro país. Rev Fac Med UNAM. 2004; 4: 145-8.
2.- Harrison WR, Merbs CF y Lathers CR. Evidence of coccidioidomycosis in the Skeleton of an ancient Arizona Indian. JID.1991; 164: 436-7.
3.- Cano MA, Sotelo CN, Contreras SJ. Coccidioidmicosis diseminada con lesión cutánea tipo chancroide. Bol Med Hosp Infant Mex. 2002; 59: 645-50.
4.- González BJ. Panorama de la Coccidioidomicosis en Nuevo León de 1978 a 1988. Gac Méd Méx. 1991; 127: 427-32.
5.- Stevens DA. Current Concepts: Coccidioidomycosis. N Engl J Med.1995; 332: 1077-82.
6.- Hernández M, Sosa LR, Ramos MR. Complejo Cutáneo-ganglionar de la coccidioidomicosis. Bol Med Hosp Infant Mex. 2002; 59: 174-8.
7.- Catanzaro A. Pulmonary Coccidioidomycosis. Med Clin North Am.1980; 79: 461-73.
8.- Laniado LR, Cárdenas MR, Alvarez CM. Tijuana: zona endémica de infección por Coccidioides immitis. Salud Pública Mex.1991; 33: 235-9.
9.- CDC. Update: Coccidioidomicosis in travelers returning from Mexico-Pennsylvania. MMWR. 2000; 49: 1004-6.
10.- Definición del caso 1996 (CDC): http//www.cdc.gov/epo/dphsi/casedef/coccidioidcurrent.htm.
11.- Einstein HE, Johnson RH. Coccidioidomycosis: New aspects of epidemiology and therapy. CID.1993; 16: 349-56.
12.- Kafka J, Catanzaro A. Disseiminated coccidioidomicosis in children. J pediatr. 1991; 98: 355-61.
13.-Cox RA, Baker BS, Stevens D. Specificity of immunoglobulin E in coccidioidomycosis and correlation with Disease Involvement. Infect Immun. 1982; 37: 609-16.
14.-Feigin RD, Cherry JD. Text book of pediatrics Infectious Disease. Ed Saunders Company; 1988. P.2314-23.
15.- Graybill JR, Stevens DA, Galgiani JN, y cols. Itraconazole Treatment of Coccidioidomycosis. Am J Med. 1990; 89: 282-90.
16.- Galgiani JN, Catanzaro A, Cloud GA, y cols. Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomicosis. Ann Intern Med. 2000; 133: 676-86.
17.- Luber AD, Maa L, Lam M, y col. Risk Factor for amphotericin B induced nephrotoxicity. JAC. 1999; 43: 267-71.
18.- Goldman RD, Koren G. Amphotericin B nephrotoxicity in children. J Pediatr Hematol Oncol. 2004; 26: 421-4.
Full text